Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Gains from Investment Securities (2019 - 2025)

China Pharma Holdings filings provide 9 years of Gains from Investment Securities readings, the most recent being -$135320.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 101.0% to -$135320.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$137454.0, a 101.01% decrease, with the full-year FY2025 number at $10000.0, down 99.93% from a year prior.
  • Gains from Investment Securities hit -$135320.0 in Q4 2025 for China Pharma Holdings, down from $13.6 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $13.6 million in Q4 2024 to a low of -$204518.0 in Q3 2023.
  • Median Gains from Investment Securities over the past 4 years was $264.5 (2021), compared with a mean of $2.2 million.
  • Biggest five-year swings in Gains from Investment Securities: soared 6632.22% in 2024 and later tumbled 101.0% in 2025.
  • China Pharma Holdings' Gains from Investment Securities stood at $519.0 in 2021, then surged by 38794.99% to $201865.0 in 2023, then soared by 6632.22% to $13.6 million in 2024, then tumbled by 101.0% to -$135320.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$135320.0 (Q4 2025), $13.6 million (Q4 2024), and $201865.0 (Q4 2023) per Business Quant data.